Proquility Private Wealth Partners, LLC Mannkind Corp Transaction History

Proquility Private Wealth Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$2.67 - $4.77 $131,203 - $234,397	49,140 New	49,140 $187,000
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $128,746 - $218,673	-49,140 Closed	0 $0
Q1 2021 Jun 08, 2021	BUY	$3.14 - $6.14 $154,299 - $301,719	49,140 New	49,140 $193,000

248

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Proquility Private Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Proquility Private Wealth Partners, LLC with notifications on news.